The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Identification of the designer steroid Androsta‐3,5‐diene‐7,17‐dione in a dietary supplement
Abstract
A liquid chromatography‐mass spectrometry (LC–MS) screen for known anabolic‐androgenic steroids in a dietary supplement product marketed for “performance enhancement” detected an unknown compound having steroid‐like spectral characteristics. The compound was isolated using high performance liquid chromatography with ultraviolet detection (HPLC–UV) coupled with an analytical scale fraction collector. After the compound was isolated, it was then characterized using gas chromatography with simultaneous Fourier Transform infrared detection and mass spectrometry (GC–FT–IR–MS), liquid chromatography–high resolution accurate mass–mass spectrometry (LC–HRAM–MS) and nuclear magnetic resonance (NMR). The steroid had an accurate mass of m/z 285.1847 (error−0.57 ppm) for the protonated species [M + H]+, corresponding to a molecular formula of C 19 H 24 O 2. Based on the GC–FT–IR–MS data, NMR data, and accurate mass, the compound was identified as androsta‐3,5‐diene‐7,17‐dione. Although this is not the first reported identification of this designer steroid in a dietary supplement, the data provided adds information for identification of this compound not previously reported. This compound was subsequently detected in another dietary supplement product, which contained three additional active ingredients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“with one report finding that synthetic oral anabolic-androgenic steroids have been detected in up to 20% of performance-enhancing drugs sold legally over the counter (35,40,41).”
From Non-testosterone management of male hypogonadism: an examination of the existing literature (2020) · cites this paper as [40]
Citations
Cites
The Handbook of infrared and Raman characteristic frequencies of organic molecules
(1992) · Choice Reviews Online · doi:10.5860/choice.29-5702 · Cited by 4,578
Recent Advances in Doping Analysis
Bassindale, T., Cowan, D., Dale, S. E. C., Hutt, A., Leeds, A., Kicman, A. T., Schanzer, H., Geyer, H., Gotzmann, A., & Mareck, U. (2002) · Cited by 547
Nutritional supplements: prevalence of use and contamination with doping agents
Thuyne, W. V., Eenoo, P. V., & Delbeke, F. T. (2006) · Nutrition Research Reviews · doi:10.1079/nrr2006122 · Cited by 110
Václavík, L., Krynitsky, A. J., & Rader, J. I. (2014) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-014-8159-z · Cited by 103
Rahnema, C. D., Crosnoe, L. E., & Kim, E. D. (2015) · Andrology · doi:10.1111/andr.307 · Cited by 101
Anabolic steroids detected in bodybuilding dietary supplements – a significant risk to public health
Abbate, V., Kicman, A. T., Evans-Brown, M. J., McVeigh, J., Cowan, D., Wilson, C., Coles, S. J., & Walker, C. J. (2014) · Drug Testing and Analysis · doi:10.1002/dta.1728 · Cited by 93
Poucke, C. V., Detavernier, C., Cauwenberghe, R. V., & Peteghem, C. V. (2006) · Analytica Chimica Acta · doi:10.1016/j.aca.2006.09.050 · Cited by 79
Synthetic Androgens as Designer Supplements
Joseph, J. F., & Parr, M. K. (2014) · Current Neuropharmacology · doi:10.2174/1570159x13666141210224756 · Cited by 60
Niebauer, J., & Sundberg, C. J. (2019) · Oxford University Press eBooks · doi:10.1093/med/9780198779742.003.0047 · Cited by 40
Thuyne, W. V., Eenoo, P. V., Mikulčíková, P., Deventer, K., & Delbeke, F. T. (2005) · Biomedical Chromatography · doi:10.1002/bmc.496 · Cited by 32
Marwah, A. K., Marwah, P., & Lardy, H. A. (2002) · Bioorganic Chemistry · doi:10.1016/s0045-2068(02)00010-x · Cited by 13
Cooper, E. R., McGrath, K. C. Y., Li, X.-H., Akram, O. N., Kasz, R., Kazlauskas, R., McLeod, M. D., Handelsman, D. J., & Heather, A. K. (2016) · Drug Testing and Analysis · doi:10.1002/dta.2000 · Cited by 13
Multianalyte LC–MS-Based Methods in Doping Control: What are The Implications for Doping Athletes?
Botrè, F., de la Torre, X., & Mazzarino, M. (2016) · Bioanalysis · doi:10.4155/bio-2016-0083 · Cited by 12
Schubert, K., Wehrberger, K., & Hobe, G. (1971) · PubMed · Cited by 2
Research works printed but not linked: 1
- Agbenyefia P, 2014, Cholestatic jaundice with the use of Methylstenbolone and Dymethazine, designer steroids found in super DMZ Rx 2.0 “nutritional supplement”: a case report, J Investig Med High Impact Case Rep, 2, 1
Cited by
Sorted by citations
Non-testosterone management of male hypogonadism: an examination of the existing literature
Krzastek, S. C., & Smith, R. P. (2020) · Translational Andrology and Urology · doi:10.21037/tau.2019.11.16 · Cited by 33
“Numerous other compounds with steroid-like structures are not regulated and have been identified in dietary supplements marketed to “enhance performance,” with one report finding that synthetic oral anabolic-androgenic steroids have been detected in up to 20% of performanceenhancing drugs sold legally over the counter…”
BackgroundBrito, D. M., de la Torre, X., Colamonici, C., Curcio, D., & Botrè, F. (2019) · Drug Testing and Analysis · doi:10.1002/dta.2734 · Cited by 11
Designer anabolic steroids: A challenge for toxicologists
Gheddar, L., Ameline, A., Raul, J., & Kintz, P. (2019) · Annales de Toxicologie Analytique · doi:10.1016/j.toxac.2019.07.001 · Cited by 7
Interest of HRMS systems in analytical toxicology: Focus on doping products
Arbouche, N., Bottinelli, C., Gerace, E., & Gheddar, L. (2021) · Annales de Toxicologie Analytique · doi:10.1016/j.toxac.2021.10.001 · Cited by 6
Brito, D. M., de la Torre, X., Parr, M. K., & Botrè, F. (2020) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.8834 · Cited by 6
Metadata
- Authors
- Lorenz, L. M., Toomey, V. M., Lanzarotta, A. C., Flurer, R. A., & Falconer, T. M.
- Affiliations
- United States Food and Drug Administration (US)
- Corresponding author
- Lorenz, Lisa M.
- Venue
- Drug Testing and Analysis
- Publisher
- Wiley
- Published
- 2019-05-03
- Volume
- 11
- Issue
- 7
- Pages
- 1109-1115
- ISSN
- 1942-7603 (ISSN-L)
- 1942-7611
- OpenAlex
- W2924990831
- Cited by
- 9
- References
- 14
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 1 · 2021: 1 · 2020: 3 · 2019: 2
- FWCI
- 3.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Drug Testing and Analysis (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Sociology and Political Science › Doping in Sports
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Pharmacological Effects and Assays
- Keywords
- designer steroids, anabolic steroids, dietary supplements, steroid identification, molecular formula determination, NMR characterization
- MeSH terms
- Androstadienes, Chromatography, High Pressure Liquid, Gas Chromatography-Mass Spectrometry, Magnetic Resonance Spectroscopy, Designer Drugs, Substance Abuse Detection, Spectroscopy, Fourier Transform Infrared, Dietary Supplements
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
